149 related articles for article (PubMed ID: 2104561)
1. Intracranial hemorrhage after use of tissue plasminogen activator for coronary thrombolysis.
Kase CS; O'Neal AM; Fisher M; Girgis GN; Ordia JI
Ann Intern Med; 1990 Jan; 112(1):17-21. PubMed ID: 2104561
[TBL] [Abstract][Full Text] [Related]
2. Intracranial hemorrhage after coronary thrombolysis with tissue plasminogen activator.
Kase CS; Pessin MS; Zivin JA; del Zoppo GJ; Furlan AJ; Buckley JW; Snipes RG; LittleJohn JK
Am J Med; 1992 Apr; 92(4):384-90. PubMed ID: 1558085
[TBL] [Abstract][Full Text] [Related]
3. Clinical features and pathogenesis of intracerebral hemorrhage after rt-PA and heparin therapy for acute myocardial infarction: the Thrombolysis in Myocardial Infarction (TIMI) II Pilot and Randomized Clinical Trial combined experience.
Sloan MA; Price TR; Petito CK; Randall AM; Solomon RE; Terrin ML; Gore J; Collen D; Kleiman N; Feit F
Neurology; 1995 Apr; 45(4):649-58. PubMed ID: 7723950
[TBL] [Abstract][Full Text] [Related]
4. TNK-tissue plasminogen activator compared with front-loaded alteplase in acute myocardial infarction: results of the TIMI 10B trial. Thrombolysis in Myocardial Infarction (TIMI) 10B Investigators.
Cannon CP; Gibson CM; McCabe CH; Adgey AA; Schweiger MJ; Sequeira RF; Grollier G; Giugliano RP; Frey M; Mueller HS; Steingart RM; Weaver WD; Van de Werf F; Braunwald E
Circulation; 1998 Dec 22-29; 98(25):2805-14. PubMed ID: 9860780
[TBL] [Abstract][Full Text] [Related]
5. Risk for intracranial hemorrhage after tissue plasminogen activator treatment for acute myocardial infarction. Participants in the National Registry of Myocardial Infarction 2.
Gurwitz JH; Gore JM; Goldberg RJ; Barron HV; Breen T; Rundle AC; Sloan MA; French W; Rogers WJ
Ann Intern Med; 1998 Oct; 129(8):597-604. PubMed ID: 9786806
[TBL] [Abstract][Full Text] [Related]
6. Intracerebral hematoma related to thrombolysis for myocardial infarction.
Kaufman HH; McAllister P; Taylor H; Schmidt S
Neurosurgery; 1993 Nov; 33(5):898-900; discussion 900-1. PubMed ID: 8264890
[TBL] [Abstract][Full Text] [Related]
7. Intracerebral hemorrhage, cerebral infarction, and subdural hematoma after acute myocardial infarction and thrombolytic therapy in the Thrombolysis in Myocardial Infarction Study. Thrombolysis in Myocardial Infarction, Phase II, pilot and clinical trial.
Gore JM; Sloan M; Price TR; Randall AM; Bovill E; Collen D; Forman S; Knatterud GL; Sopko G; Terrin ML
Circulation; 1991 Feb; 83(2):448-59. PubMed ID: 1899364
[TBL] [Abstract][Full Text] [Related]
8. Lower-dose heparin with fibrinolysis is associated with lower rates of intracranial hemorrhage.
Giugliano RP; McCabe CH; Antman EM; Cannon CP; Van de Werf F; Wilcox RG; Braunwald E;
Am Heart J; 2001 May; 141(5):742-50. PubMed ID: 11320361
[TBL] [Abstract][Full Text] [Related]
9. [Intracranial hemorrhage following second thrombolytic treatment of myocardial reinfarction].
Valentín Segura V; Valls Grima F; Broch Porcar MJ; Miralles Serrano L; Olivares Toledo D; Alvarez Cebrián F
Rev Esp Cardiol; 1994 Dec; 47(12):836-8. PubMed ID: 7855379
[TBL] [Abstract][Full Text] [Related]
10. Intracerebral hemorrhage after combined anticoagulant-thrombolytic therapy for myocardial infarction: two case reports and a short review.
Da Silva VF; Bormanis J
Neurosurgery; 1992 Jun; 30(6):943-5. PubMed ID: 1614602
[TBL] [Abstract][Full Text] [Related]
11. Prediction of 30-day mortality among patients with thrombolysis-related intracranial hemorrhage.
Sloan MA; Sila CA; Mahaffey KW; Granger CB; Longstreth WT; Koudstaal P; White HD; Gore JM; Simoons ML; Weaver WD; Green CL; Topol EJ; Califf RM
Circulation; 1998 Oct; 98(14):1376-82. PubMed ID: 9760291
[TBL] [Abstract][Full Text] [Related]
12. Admission fibrinolytic profile is associated with symptomatic hemorrhagic transformation in stroke patients treated with tissue plasminogen activator.
Ribo M; Montaner J; Molina CA; Arenillas JF; Santamarina E; Quintana M; Alvarez-Sabín J
Stroke; 2004 Sep; 35(9):2123-7. PubMed ID: 15243150
[TBL] [Abstract][Full Text] [Related]
13. Unsuspected vasculitis and intracranial hemorrhage following thrombolysis.
Srinivasan G; Boschman C; Roth SI; Hendel RC
Clin Cardiol; 1997 Jan; 20(1):84-6. PubMed ID: 8994745
[TBL] [Abstract][Full Text] [Related]
14. Intracerebral hemorrhage complicating intravenous tissue plasminogen activator treatment.
Carlson SE; Aldrich MS; Greenberg HS; Topol EJ
Arch Neurol; 1988 Oct; 45(10):1070-3. PubMed ID: 3140769
[TBL] [Abstract][Full Text] [Related]
15. Stroke after thrombolysis. Mortality and functional outcomes in the GUSTO-I trial. Global Use of Strategies to Open Occluded Coronary Arteries.
Gore JM; Granger CB; Simoons ML; Sloan MA; Weaver WD; White HD; Barbash GI; Van de Werf F; Aylward PE; Topol EJ
Circulation; 1995 Nov; 92(10):2811-8. PubMed ID: 7586246
[TBL] [Abstract][Full Text] [Related]
16. Cerebral aneurysm rupture after r-TPA thrombolysis for acute myocardial infarction.
Lagares A; Gómez PA; Lobato RD; Alén JF; Campollo J; Benito-León J
Surg Neurol; 1999 Dec; 52(6):623-6. PubMed ID: 10660031
[TBL] [Abstract][Full Text] [Related]
17. Thrombolysis-related intracranial hemorrhage: a radiographic analysis of 244 cases from the GUSTO-1 trial with clinical correlation. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries.
Gebel JM; Sila CA; Sloan MA; Granger CB; Mahaffey KW; Weisenberger J; Green CL; White HD; Gore JM; Weaver WD; Califf RM; Topol EJ
Stroke; 1998 Mar; 29(3):563-9. PubMed ID: 9506593
[TBL] [Abstract][Full Text] [Related]
18. Cerebral venous congestion as indication for thrombolytic treatment.
Tsai FY; Kostanian V; Rivera M; Lee KW; Chen CC; Nguyen TH
Cardiovasc Intervent Radiol; 2007; 30(4):675-87. PubMed ID: 17573553
[TBL] [Abstract][Full Text] [Related]
19. Factors related to intracranial hematoma formation in patients receiving tissue-type plasminogen activator for acute ischemic stroke.
Levy DE; Brott TG; Haley EC; Marler JR; Sheppard GL; Barsan W; Broderick JP
Stroke; 1994 Feb; 25(2):291-7. PubMed ID: 8303734
[TBL] [Abstract][Full Text] [Related]
20. Spontaneous suprachoroidal hemorrhage secondary to thrombolysis for the treatment of myocardial infarction.
Barsam A; Heatley CJ; Herbert L
Clin Exp Ophthalmol; 2006 Mar; 34(2):177-9. PubMed ID: 16626438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
